Poseida Therapeutics, Inc.
PSTX
|
$2.07
-4.17%
-4.6%
460K
|
Health Technology
(0.0% 1d) (-26.3% 1m) (-15.5% 1y) (0.0% 2d) (-4.2% 3d) (2.5% 7d) (7.9% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 199,732,493
http://www.poseida.com
Sec Filling | Patents | 149 employees
(US) Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
car-t t-cell treatment ceiling
add to watch list Paper trade email alert is off
Press-releases
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cell meeting therapeutics therapy
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: 0.0%
H: 2.46%
C: 0.49%
day pipeline therapeutics therapy
Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
car-t therapeutics potential therapy
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-01 (Crawled : 20:00) - prnewswire.com
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: -1.79%
H: 1.0%
C: -3.65%
nasdaq grant therapeutics
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Published: 2024-03-25 (Crawled : 20:00) - prnewswire.com
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: 1.64%
H: 0.97%
C: -9.06%
medical therapeutics
Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Published: 2024-03-19 (Crawled : 20:00) - prnewswire.com
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: -1.03%
H: 6.94%
C: 3.13%
conference cell therapeutics therapy
Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma
Published: 2024-03-13 (Crawled : 20:00) - prnewswire.com
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: -4.14%
fda drug granted treatment designation therapeutics
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: 0.84%
H: 0.28%
C: -5.25%
year therapeutics financial results
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-04 (Crawled : 21:00) - prnewswire.com
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: -0.95%
H: 2.74%
C: -4.66%
nasdaq grant therapeutics
CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-23 (Crawled : 22:00) - prnewswire.com
ACLX | $52.82 -2.98% -3.12% 310K
|
|
| O: 1.59%
H: 1.14%
C: -1.42%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
PSTX | $2.07 -4.17% -4.6% 460K
|
Health Technology
|
| O: 1.57%
H: 4.94%
C: 1.54%
INCY | $51.74 0.17% 0.14% 1.6M
|
Health Technology
|
| O: 0.29%
H: 0.15%
C: -1.95%
BEAM | $22.74 -3.11% -3.21% 130
|
Health Technology
|
| O: 1.88%
H: 0.88%
C: -2.79%
t-cell therapy growth study market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0000950170-24-010943 | 4 | 2024-02-03 | 2024-02-01 | Sell | F | 47162 | 685448 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Last 48 Hours Insiders Buying
MNSB P 1470 | $15.89 -2.87% -3.02% 46K
|
Finance
|
12:00
RKT P 347 | $12.55 -0.63% 1.12% 1.5M
|
Finance
|
22:30
NWFL | News | $24.21 0.42% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.68 -0.73% 39.71% 0
|
Utilities
|
20:01
RMCF | $3.55 0.28% 0.28% 7.1K
|
Consumer Non-Durables
|
20:10